Thanks @BilkentGenetics for inviting me to my alma mater @BilkentUniv. It was a joy to meet the bright students of today; training to be the successful scientists of future.

@_KUTTAM_ @kocuniversity @Tbo_Lab my team aims to interrogate the mechanisms of epigenetic regulation of cancer therapy resistance, utilizing state-of-the art CRISPR based screens, chemical biology and animal models. Applications are open!

24 postdoc positions open in the field of nanobiotechnology and cancer research! NANOBIO4CAN, with European funding and extremely good benefits, allows for recruitment of successful candidates to the top research institutes of Turkey. Please contact me if you are interested👇

On my way to #EACR2023 in Torino with 6 members of @Tbo_Lab See you there☺️

Tıp Fakültesi’nden Prof. Dr. Tuğba Bağcı Önder, Koç Üniversitesi Translasyonel Tıp Uygulama ve Araştırma Merkezi’nden doktora sonrası araştırmacı Dr. Alişan Kayabölen ve ekip arkadaşları, COVID-19 salgınına neden olan SARS-CoV2 ile mücadelede yeni bir molekül tasarladılar.

A new article from us, @ozlemyedier @Tbo_Lab and @Tamer_Onder at @cddpress. We describe a focused sgRNA library targeting epigenetic modifiers and name it “EPIKOL”. EPIKOL has great potential to identify novel cancer-specific epigenetic vulnerabilities. https://t.co/f4aQOh0qzb

Thanks to the creative design and perseverance of @alisankayabolen, and great collaboration between @Tbo_Lab from @kocuniversity, @kuiscid, @_KUTTAM_ and @TUBITAK_MAM, this work was possible.

Today is a big day! We present our work on novel multimeric forms of ACE2, which work very efficiently in neutralizing SARS-CoV-2 infection. These smartly designed decoys potently block the variants of concern as well! https://t.co/tQUwIGLlIR

New paper from @Tbo_Lab! 🎊🎈 Congratulations @alisankayabolen.👏 A novel treatment approach for SARS-CoV-2 Infection: "Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In Vivo" https://t.co/TWg7xeN4pT

My heart is broken into pieces: Rest in peace @cemreucaryilmaz I feel happy to have known you, be inspired from you at every level, as your teacher, as a big sister, as a cancer survivor, as a cancer researcher +

Great science is loading… #icds2022istanbul is starting in an hour. Couldn’t have asked for a better organization team @Tbo_Lab @DevrimGozuacik lab!

Let #icds2022istanbul begin. Last minute checks…

Final countdown to #ICDS2022 in İstanbul. Proud to be an organizer of this wonderful event of @IntCellDeathSoc at @kocuniversity this year! Thanks @_KUTTAM_ and The School of Medicine for their support👇

Excited to host another great seminar tomorrow. Please join to hear about cancer cell dormancy and metastatic awakening from @das_cancerbio 👇

Great talk from our KUSOM undergraduate Gizem Yasa 👏🏻👏🏻👏🏻 at #kusomresearchdays @KU_Medicine. Go Team IDH!

Last but not least, we also did sightseeing and had a lot of fun. We loved Helsinki!🇫🇮

@nareg_pinar with her poster "Establishment of clinically relevant radioresistant glioblastoma cell models" 🧠

@EzgiYagmurKala with her poster "Generation of Temozolomide Resistant Glioblastoma Models and Identification of Chromatin Modifiers Important for Resistance" 🧠

@GoktugKarabiyik with his poster "Identification of epigenetic vulnerabilities of chemo- resistant medulloblastoma" 🧠 heated discussions!

Ebru with her poster "KDM6A/6B Regulates Cholesterol Biosynthesis in IDH1 Mutant Glioma"🧠